Beijing Leadman Biochemistry Co Ltd (300289) - Total Liabilities
Based on the latest financial reports, Beijing Leadman Biochemistry Co Ltd (300289) has total liabilities worth CN¥97.10 Million CNY (≈ $14.21 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Beijing Leadman Biochemistry Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Beijing Leadman Biochemistry Co Ltd - Total Liabilities Trend (2008–2025)
This chart illustrates how Beijing Leadman Biochemistry Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 300289 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Beijing Leadman Biochemistry Co Ltd Competitors by Total Liabilities
The table below lists competitors of Beijing Leadman Biochemistry Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Shenzhen Longli Technology Co Ltd Class A
SHE:300752
|
China | CN¥1.02 Billion |
|
Spire Global Inc
NYSE:SPIR
|
USA | $91.65 Billion |
|
Jiangsu Hengxing New Material
SHG:603276
|
China | CN¥124.51 Million |
|
Hanwha General
KO:000370
|
Korea | ₩18.07 Trillion |
|
Fujian Tendering Co. Ltd.
SHE:301136
|
China | CN¥554.83 Million |
|
Ledman Optoelectronic Co Ltd
SHE:300162
|
China | CN¥713.97 Million |
|
Braskem S.A.
SA:BRKM3
|
Brazil | R$90.56 Billion |
|
Shenzhen Keanda Electronic Techno
SHE:002972
|
China | CN¥206.27 Million |
Liability Composition Analysis (2008–2025)
This chart breaks down Beijing Leadman Biochemistry Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Beijing Leadman Biochemistry Co Ltd market capitalisation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 13.99 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.06 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.06 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Beijing Leadman Biochemistry Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Beijing Leadman Biochemistry Co Ltd (2008–2025)
The table below shows the annual total liabilities of Beijing Leadman Biochemistry Co Ltd from 2008 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥105.46 Million ≈ $15.43 Million |
+1.56% |
| 2024-12-31 | CN¥103.84 Million ≈ $15.19 Million |
-22.37% |
| 2023-12-31 | CN¥133.77 Million ≈ $19.57 Million |
-38.26% |
| 2022-12-31 | CN¥216.67 Million ≈ $31.71 Million |
-41.49% |
| 2021-12-31 | CN¥370.30 Million ≈ $54.19 Million |
+48.17% |
| 2020-12-31 | CN¥249.92 Million ≈ $36.57 Million |
-5.39% |
| 2019-12-31 | CN¥264.18 Million ≈ $38.66 Million |
-9.47% |
| 2018-12-31 | CN¥291.80 Million ≈ $42.70 Million |
-11.23% |
| 2017-12-31 | CN¥328.73 Million ≈ $48.10 Million |
+0.80% |
| 2016-12-31 | CN¥326.13 Million ≈ $47.72 Million |
-18.21% |
| 2015-12-31 | CN¥398.76 Million ≈ $58.35 Million |
-23.82% |
| 2014-12-31 | CN¥523.48 Million ≈ $76.60 Million |
+33.25% |
| 2013-12-31 | CN¥392.86 Million ≈ $57.49 Million |
+6.42% |
| 2012-12-31 | CN¥369.17 Million ≈ $54.02 Million |
+154.80% |
| 2011-12-31 | CN¥144.89 Million ≈ $21.20 Million |
+46.36% |
| 2010-12-31 | CN¥98.99 Million ≈ $14.49 Million |
+107.62% |
| 2009-12-31 | CN¥47.68 Million ≈ $6.98 Million |
+58.91% |
| 2008-12-31 | CN¥30.01 Million ≈ $4.39 Million |
-- |
About Beijing Leadman Biochemistry Co Ltd
Beijing Leadman Biochemistry Co.,Ltd. researches and develops, manufactures, and sells vitro diagnostic reagents and instruments, and biochemical raw materials in the People's Republic of China. The company offers biochemical raw materials, including enzymes, antigens, coenzymes, antibodies, buffers, enzyme substrates, culture mediums, stain agents, amino acids, and other products for biotechnolo… Read more